Morgan Stanley Call 65 INCY 20.09.../ DE000ME9GR71 /
2024-07-05 9:26:37 PM | Chg.0.000 | Bid10:00:34 PM | Ask10:00:34 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.570EUR | 0.00% | - Bid Size: - |
- Ask Size: - |
Incyte Corporation | 65.00 USD | 2024-09-20 | Call |
GlobeNewswire
06-25
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...
GlobeNewswire
05-09
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire
05-08
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
04-02
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...
GlobeNewswire
04-01
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...
GlobeNewswire
02-28
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire
01-09
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire
2023-12-09
CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
GlobeNewswire
2023-11-16
CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...
GlobeNewswire
2023-11-02
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
GlobeNewswire
2023-10-23
Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...
GlobeNewswire
2023-08-28
Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer
GlobeNewswire
2022-03-23
RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation An...
GlobeNewswire
2022-03-14
STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations